
According to the report by KAN, the officer allegedely made made sexually explicit statements towards his subordinate, with the incident being investigated.
An officer from Lahav 433, Israel's "FBI," is being investigated after he sexually harassed a policewoman who was working as his direct subordinate, KAN reported on Friday.
According to the report, the officer allegedely made made sexually explicit statements towards his subordinate.
The policewoman was transferred from the unit to separate her from the officer, while the suspect was kept on duty, the report stated.
Israel Police told Kan that the matter was sent to the force's internal affairs unit, the Criminal Investigation Department, for investigation the moment the reports became known.
Explicit comments, harassment towards a subordinate
The report mentioned that one of the incidents, registered last month, happened around unwanted physical contact after a meeting.
Kan said that the officer touched the policewoman's leg under the table and was promptly pushed away by the victim.
He then reportedly told her, "Let me f*** you."
The report mentioned that several other incidents in which he allegedly made sexually explicit statements are also being investigated as part of an internal investigation.
LATEST POSTS
- 1
Four countries to boycott Eurovision 2026 over Israel’s inclusion - 2
Four Dead in Last Month From Animal Attacks in Nepal - 3
The Force of Systems administration: Individual Examples of overcoming adversity - 4
NASA Artemis II tracker: Crew less than 60,000 miles from moon ahead of Monday flyby - 5
Putin critic gets six years in penal colony, vows hunger strike
Carrefour becomes first European retailer to offer shopping on ChatGPT
Careful Living: Embracing the Current Second
We may have one thing in common with jellyfish, new research finds
Paris Agreement target off the table, report says
6 Famous kind of practice on the planet
Heading to Florida for NASA's Artemis 2 moon launch? Here's what to know before you go
Pick Your #1 Japanese Food
How will the universe end?
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet













